Prostate Cancer: Metastatic Late Stage

Insurance Coverage & Financial Assistance

Genomic Health believes that everyone should have access to the information they need to make confident, informed decisions about their cancer treatments. Through GAP, Genomic Health takes every possible step to ensure testing is affordable, available, and accessible. That's why Genomic Health created the Genomic Access Program (GAP), which helps eligible patients navigate insurnace and other payment options. Contact Customer Service by phone 888-ONCOTYPE (888-662-6897) or by email at

Insurance coverage

Medicare now covers the Oncotype DX AR-V7 Nucleus Detect test for patients with metastatic castration-resistant prostate cancer. If your private insurance covers the test, our GAP team will:

  • Work with your physician to get prior authorization from your insurance company (if required).
  • Bill your insurance directly when possible.
  • Process the claim once the test is complete.
  • Assist in the review process if a claim is denied.

To get started with GAP, contact Customer Service at 888-ONCOTYPE (888-662-6897).

Financial assistance

Genomic Health offers financial assistance programs for eligible patients with financial hardship. These programs are based on financial eligibility. Contact Customer Service by phone at 888-ONCOTYPE (888-662-6897) or via email at for more information.

Stay in Touch

Have a specific question? Want to keep up with our latest news? We're here for you.

Contact Us
Making cancer care smarter.™

We may use cookies to improve your experience with our website and to provide you with more relevant content based on your interests. To learn more about what information we collect, how we use it, and how to manage cookies, review our Privacy Policy.